Atazanavir & Ritonavir Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 300 mg Atazanavir + 100 mg Ritonavir
Reference Brands: Evotaz®(US)
Category: Anti Viral
Atazanavir/Ritonavir Tablets (300/100 mg) are key antiretrovirals for HIV-1 treatment. Available via PharmaB2B from WHO-GMP and USFDA-approved suppliers, this fixed-dose combo ensures boosted efficacy and once-daily convenience. Ideal for global procurement, tenders, and HIV programs seeking compliant, cost-effective sourcing.
Product Description:
Atazanavir & Ritonavir Tablets are a fixed-dose antiretroviral combination used in the management of HIV-1 infection, with Ritonavir boosting Atazanavir’s effectiveness. Available in a 300 mg + 100 mg formulation, this once-daily therapy is WHO-recommended and USFDA-approved. On PharmaB2B platforms, global buyers can connect with GMP-certified manufacturers for bulk procurement of quality-assured Atazanavir/Ritonavir tablets. Ideal for hospitals, NGOs, government tenders, and HIV treatment programs, PharmaB2B simplifies sourcing of affordable, compliant ARVs. Partner with reliable suppliers to support uninterrupted access to essential HIV care in both regulated and emerging markets.
Atazanavir & Ritonavir — third party manufacturing & bulk supply
Atazanavir & Ritonavir is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Atazanavir & Ritonavir listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Atazanavir & Ritonavir →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Atazanavir and ritonavir are used together to treat HIV-1 infection. Atazanavir is a protease inhibitor, and ritonavir is used in a low dose to boost atazanavir levels, helping reduce viral load and improve immune function as part of combination antiretroviral therapy.
This combination is made from two antiretroviral agents: atazanavir sulfate, a protease inhibitor, and ritonavir, another protease inhibitor used as a pharmacokinetic enhancer to increase atazanavir's effectiveness.
The commonly known trade name for the fixed-dose combination is not globally standardized, but the regimen is often used clinically as “Atazanavir boosted with Ritonavir.” Atazanavir alone is branded as Reyataz.
Atazanavir (Reyataz) is manufactured by Bristol-Myers Squibb (BMS). Ritonavir (Norvir) is manufactured by AbbVie. Many generic manufacturers produce the combination for various markets.
The generic name is atazanavir and ritonavir.
While no single fixed-dose brand is universally marketed, the individual brands are Reyataz (atazanavir) and Norvir (ritonavir). In practice, the combination is referred to as atazanavir/ritonavir.
Manufacturing occurs in multiple approved facilities across the USA, Europe, and India, depending on the innovator or generic manufacturer supplying the product.
Related Products
Brincidofovir
Strength:
100 mg, 10 mg/ml
Form: Tablets / Oral suspension
Reference Brands: Tembexa (USA/EU)
View Details
Lenacapavir
Strength:
300 mg, 463.5 mg/1.5 mL
Form: Tablet / Injection
Reference Brands: Yeztugo (USA), Sunlenca (USA)
View Details
Quick Response Guaranteed | Verified Suppliers
